Justin Bowers
Stock Analyst at Deutsche Bank
(1.86)
# 3,245
Out of 5,152 analysts
40
Total ratings
37.5%
Success rate
4.36%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $375 → $315 | $315.59 | -0.19% | 4 | Aug 5, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $469.38 | -8.39% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $178.50 | +48.46% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $9.92 | +131.85% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $23.45 | +23.67% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $21.64 | +15.53% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $125.03 | +23.97% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $518.84 | +17.57% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $55.89 | +46.72% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $8.52 | +193.43% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $3.68 | +361.96% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $110.60 | +171.25% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $202.00 | +36.14% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $244.35 | +2.31% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $181.32 | +59.94% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $16.25 | +183.08% | 5 | May 10, 2021 |
Waters
Aug 5, 2025
Maintains: Hold
Price Target: $375 → $315
Current: $315.59
Upside: -0.19%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $469.38
Upside: -8.39%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $178.50
Upside: +48.46%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $9.92
Upside: +131.85%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $23.45
Upside: +23.67%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $21.64
Upside: +15.53%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $125.03
Upside: +23.97%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $518.84
Upside: +17.57%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $55.89
Upside: +46.72%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $8.52
Upside: +193.43%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $3.68
Upside: +361.96%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $110.60
Upside: +171.25%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $202.00
Upside: +36.14%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $244.35
Upside: +2.31%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $181.32
Upside: +59.94%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $16.25
Upside: +183.08%